Female (N=245) | Male (N=345) | p Value | |
---|---|---|---|
HAQ | 0.81 (0.68) | 0.48 (0.63) | <0.001 |
DLQI | 4.1 (5.1) | 3.7 (4.5) | 0.35 |
FSS | 5 (3.1) | 4.1 (3) | <0.001 |
SF-36 (PCS) | 37.8 (11.1) | 42.4 (11.9) | <0.001 |
SF-36 (MCS) | 47.3 (11.5) | 48.1 (10.9) | 0.41 |
BASFI | 3.6 (2.7) | 2.5 (2.7) | <0.001 |
Disabled at diagnosis of PsA | 11 (4.6%) | 8 (2.4%) | 0.31 |
Disabled: current | 30 (12.2%) | 37 (10.8%) | 0.57 |
BASFI, Bath Ankylosing Spondylitis Functional Index; DLQI, Disease Life Quality Index; FSS, Fatigue Severity Score; HAQ, Health Assessment Questionnaire; PsA, psoriatic arthritis; SF-36 (MCS), The Medical Outcome Study Short Form Health Survey, mental component score; SF-36 (PCS), The Medical Outcome Study Short Form Health Survey, physical component score.